Search results
Results from the WOW.Com Content Network
Mefenamic acid is generic and is available worldwide under many brand names. [6] In the US, wholesale price of a week's supply of generic mefenamic acid has been quoted as $426.90 in 2014. Brand-name Ponstel is $571.70. [34] By contrast, in the UK, a weeks supply is £1.66, or £8.17 for branded Ponstan. [35]
(Top) 1 Antipsychotics. ... Following is a list of antipsychotics, sorted by class. ... Brand Names Chemical class ATC code Antipsychotic esters
This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.
Brand names and generic names are differentiated by capitalizing brand names. See also the list of the top 100 bestselling branded drugs, ranked by sales. Abbreviations are used in the list as follows: INN = International nonproprietary name; BAN = British Approved Name; USAN = United States Adopted Name; Two-letter codes for countries
Fenamic acid is an organic compound, which, especially in its ester form, is called fenamate. [ 1 ] : 458 serves as a parent structure for several nonsteroidal anti-inflammatory drugs (NSAIDs), including mefenamic acid , tolfenamic acid , flufenamic acid , and meclofenamic acid .
Contraindications are hypersensitivity to phenazone, propyphenazone, aminophenazone, metamizol, phenylbutazone, paracetamol, acetylsalicylic acid, or caffeine; bone marrow deficiencies; glucose-6-phosphate dehydrogenase deficiency; acute hepatic porphyria; alcoholism; gastrointestinal ulcers or bleeding; pregnancy and lactation; infants and ...
Meclofenamic acid (used as meclofenamate sodium, brand name Meclomen) is a drug used for joint, muscular pain, arthritis and dysmenorrhea. [1] It is a member of the anthranilic acid derivatives (or fenamate) class of nonsteroidal anti-inflammatory drugs (NSAIDs) and was approved by the US FDA in 1980. [ 2 ]
In October 2020, the U.S. Food and Drug Administration (FDA) required the drug label to be updated for all nonsteroidal anti-inflammatory medications to describe the risk of kidney problems in unborn babies that result in low amniotic fluid. [5] [6] They recommend avoiding NSAIDs in pregnant women at 20 weeks or later in pregnancy. [5] [6]